In this 2-minute video, Prof. Dr. Lieven Annemans explains how payers decide on reimbursing a new treatment based on the number of QALYs gained, and how that differs between countries.
It’s a great video with animation!
🎓 If you want to learn more about:
- The logic and math behind QALYs, ICERs, decision-trees and Markov models.
- How external stakeholders use and challenge health economic evidence.
- To distinguish good from bad health economic evaluation studies (of your brand or its competitors).
- Key principles of cost-effectiveness analysis and Budget Impact Analysis.
- The role of health economic evaluations in clinical research, pricing & reimbursement decisions, and post-launch.
👉 Attend Prof. Dr. Lieven Annemans’ highly praised course:
Health Economics for Non-Health-Economists
With Prof. Dr. Lieven Annemans
If your budget or agenda doesn’t allow you to join us in Brussels for 2 immersive days of learning, our Self-Study Programme Basics of Health Economics allows you to learn from Prof. Dr. Lieven Annemans at your own pace and from a location of your choice, during a 4 week time frame:
Online Self-Study Programme: Basics of Health Economics
With Prof. Dr. Lieven Annemans